阿加曲班治疗急性缺血性卒中中国专家共识2021

2021-09-20 北京神经科学学会血管神经病学专业委员会 中国卒中杂志

卒中是严重危害人类健康的疾病之一,具有高发病率、高残疾率、高死亡率和高复发率的特点,现已成为我国居民(尤其是农村人群)死亡的首要病因,其中急性缺血性卒中约占70%。

中文标题:

阿加曲班治疗急性缺血性卒中中国专家共识2021

发布日期:

2021-09-20

简要介绍:

卒中是严重危害人类健康的疾病之一,具有高发病率、高残疾率、高死亡率和高复发率的特点,现已成为我国居民(尤其是农村人群)死亡的首要病因,其中急性缺血性卒中(acute ischemicstroke,AIS)约占70%[1-2]。目前AIS的治疗原则是在治疗时间窗内进行静脉溶栓和(或)血管内治疗(endovascular therapy,EVT),并针对不同病因采取相应的治疗措施,包括抗血小板聚集、抗凝、降血压、降脂和康复治疗等,以减少神经功能残疾和改善疾病预后[3-5]。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=阿加曲班治疗急性缺血性卒中中国专家共识2021.pdf)] GetToolGuiderByIdResponse(projectId=1, id=fb6591c0022366f0, title=阿加曲班治疗急性缺血性卒中中国专家共识2021, enTitle=, guiderFrom=中国卒中杂志, authorId=0, author=, summary=卒中是严重危害人类健康的疾病之一,具有高发病率、高残疾率、高死亡率和高复发率的特点,现已成为我国居民(尤其是农村人群)死亡的首要病因,其中急性缺血性卒中约占70%。, cover=https://img.medsci.cn/20211025/1635140959382_1608702.jpg, journalId=0, articlesId=null, associationId=2049, associationName=北京神经科学学会血管神经病学专业委员会, associationIntro=北京神经科学学会血管神经病学专业委员会, copyright=0, guiderPublishedTime=Mon Sep 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">卒中是严重危害人类健康的疾病之一,具有高发病率、高残疾率、高死亡率和高复发率的特点,现已成为我国居民(尤其是农村人群)死亡的首要病因,其中急性缺血性卒中(acute ischemicstroke,AIS)约占70%[1-2]。目前AIS的治疗原则是在治疗时间窗内进行静脉溶栓和(或)血管内治疗(endovascular therapy,EVT),并针对不同病因采取相应的治疗措施,包括抗血小板聚集、抗凝、降血压、降脂和康复治疗等,以减少神经功能残疾和改善疾病预后[3-5]。&nbsp;</span></p>, tagList=[TagDto(tagId=31599, tagName=阿加曲班)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=31599, guiderKeyword=阿加曲班, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7333, appHits=369, showAppHits=0, pcHits=541, showPcHits=6960, likes=3, shares=37, comments=12, approvalStatus=1, publishedTime=Mon Oct 25 16:56:23 CST 2021, publishedTimeString=2021-09-20, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Mon Oct 25 16:46:22 CST 2021, updatedBy=6415643, updatedName=凯晨, updatedTime=Wed Jan 03 16:25:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=阿加曲班治疗急性缺血性卒中中国专家共识2021.pdf)])
阿加曲班治疗急性缺血性卒中中国专家共识2021.pdf
下载请点击:
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1236157, encodeId=1bec123615e68, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb768257928, createdName=ms3000000776729511, createdTime=Tue Aug 02 15:29:13 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205098, encodeId=11421205098ed, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51de1772101, createdName=ms1529274193131620, createdTime=Wed Mar 23 04:07:27 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181839, encodeId=0d2f118183998, content=l好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42cf6453217, createdName=ms1000000489067778, createdTime=Fri Jan 07 13:50:48 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077667, encodeId=2b1b10e766731, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Tue Dec 07 09:51:54 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068592, encodeId=4f1c1068592e6, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afb75700817, createdName=ms2000001481518311, createdTime=Tue Nov 09 14:19:12 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2022-08-02 ms3000000776729511

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1236157, encodeId=1bec123615e68, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb768257928, createdName=ms3000000776729511, createdTime=Tue Aug 02 15:29:13 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205098, encodeId=11421205098ed, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51de1772101, createdName=ms1529274193131620, createdTime=Wed Mar 23 04:07:27 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181839, encodeId=0d2f118183998, content=l好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42cf6453217, createdName=ms1000000489067778, createdTime=Fri Jan 07 13:50:48 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077667, encodeId=2b1b10e766731, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Tue Dec 07 09:51:54 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068592, encodeId=4f1c1068592e6, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afb75700817, createdName=ms2000001481518311, createdTime=Tue Nov 09 14:19:12 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2022-03-23 ms1529274193131620

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1236157, encodeId=1bec123615e68, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb768257928, createdName=ms3000000776729511, createdTime=Tue Aug 02 15:29:13 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205098, encodeId=11421205098ed, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51de1772101, createdName=ms1529274193131620, createdTime=Wed Mar 23 04:07:27 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181839, encodeId=0d2f118183998, content=l好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42cf6453217, createdName=ms1000000489067778, createdTime=Fri Jan 07 13:50:48 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077667, encodeId=2b1b10e766731, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Tue Dec 07 09:51:54 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068592, encodeId=4f1c1068592e6, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afb75700817, createdName=ms2000001481518311, createdTime=Tue Nov 09 14:19:12 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2022-01-07 ms1000000489067778

    l好!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1236157, encodeId=1bec123615e68, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb768257928, createdName=ms3000000776729511, createdTime=Tue Aug 02 15:29:13 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205098, encodeId=11421205098ed, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51de1772101, createdName=ms1529274193131620, createdTime=Wed Mar 23 04:07:27 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181839, encodeId=0d2f118183998, content=l好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42cf6453217, createdName=ms1000000489067778, createdTime=Fri Jan 07 13:50:48 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077667, encodeId=2b1b10e766731, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Tue Dec 07 09:51:54 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068592, encodeId=4f1c1068592e6, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afb75700817, createdName=ms2000001481518311, createdTime=Tue Nov 09 14:19:12 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-12-07 liuyingying35

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1236157, encodeId=1bec123615e68, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb768257928, createdName=ms3000000776729511, createdTime=Tue Aug 02 15:29:13 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205098, encodeId=11421205098ed, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51de1772101, createdName=ms1529274193131620, createdTime=Wed Mar 23 04:07:27 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181839, encodeId=0d2f118183998, content=l好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42cf6453217, createdName=ms1000000489067778, createdTime=Fri Jan 07 13:50:48 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077667, encodeId=2b1b10e766731, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Tue Dec 07 09:51:54 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068592, encodeId=4f1c1068592e6, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afb75700817, createdName=ms2000001481518311, createdTime=Tue Nov 09 14:19:12 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 ms2000001481518311

    学习

    0